Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5262_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Table of contents
- •Preface
- •Abbreviations
- •1.9 Know the Mechanism of the Reactions You Perform
- •1. Opinions and Suggestions
- •1.1 Be a “Doctor,” Not Just a “Drug Fetcher”
- •1.4 Reduce Mistakes in Your Synthetic Work
- •1.5 Your Knowledge, Experience, and Skills Can Never Be Too Much
- •1.6 What Is a Mistake?
- •1.8 Improve Your Decision-Making Ability
- •1.14 Two Examples
- •References
- •2.1 Reaction Mechanism
- •2.2 Approaches to Draw Reaction Mechanism
- •2.2.1 Linear Way: Catalytic and Noncatalytic Reactions
- •2.2.2 Cyclic Way: Catalytic Reactions
- •2.3 Desired Product
- •2.4 Unexpected Product
- •2.5 Side Reaction
- •2.6 Side Product and By-product
- •2.7 Impurity
- •2.9 Intermediate
- •2.10 Transition State
- •2.11 Species
- •2.12 Free Radical
- •2.13 Stoichiometric Reaction
- •2.14 Catalytic Reaction
- •2.15 Material Balance
- •2.16 Electron Balance
- •2.17 Nucleophile
- •2.18 Electrophile
- •2.19 Acid
- •2.20 Base
- •2.22 Acid–Base Reaction
- •2.23 Reaction Selectivity
- •2.24 Chemoselectivity
- •2.25 Regioselectivity
- •2.26 Stereoselectivity
- •2.27 Iteroselectivity
- •2.28 One-pot Synthesis/Telescoping Process
- •2.29 Cascade Reaction
- •2.30 Multicomponent Reaction
- •2.31 Flow Chemistry
- •2.32 Atom Economy
- •2.33 Green Chemistry
- •2.35 Linear Synthesis and Convergent Synthesis
- •2.36 Divergent Synthesis
- •2.37 Click Chemistry
- •2.38 Parallel Synthesis
- •2.39 Solid-phase Synthesis
- •2.40 Combinatorial Chemistry
- •2.41 Process Chemist versus Medicinal Chemist
- •References
- •3. General Terms and Concepts in Medicinal Chemistry
- •3.1 What Is a Drug?
- •3.2 Drug Discovery
- •3.3 Medicinal Chemistry
- •3.4 Drug Target
- •3.5 Enzyme
- •3.6 Receptor
- •3.7 Inhibitor
- •3.8 Activator
- •3.9 Drug Design
- •3.10 Ligand-based Drug Design
- •3.11 Structure-based Drug Design
- •3.12 Lipinski’s Rule of Five
- •3.13 Lead Compound
- •3.14 Hit-to-Lead
- •3.15 High-Throughput Screening
- •3.16 Pharmacophore
- •3.17 Affinity, Efficacy, and Potency
- •3.18 Structure–Activity Relationship
- •3.19 Partition Coefficient and Log P/Clog P
- •3.20 Drug Candidate
- •3.21 Preclinical Studies
- •3.22 Toxicity
- •3.23 Pharmacokinetics and Pharmacodynamics
- •3.25 Bioavailability
- •3.26 Pharmacology
- •3.27 Formulation
- •3.28 Active Pharmaceutical Ingredient
- •3.29 Drug Stability
- •3.30 Prodrugs
- •3.31 Deuterium-containing Drug
- •3.32 Antibody Drug Conjugates
- •3.33 Good Laboratory Practice
- •3.34 Good Manufacturing Practice
- •3.35 Chemistry, Manufacturing, and Controls
- •3.36 Contract Research Organization
- •3.37 Investigational New Drug Application
- •3.38 Clinical Trials
- •3.39 New Drug Application
- •References
- •4.1 Formation of Noncyclic Compounds
- •Problem 2: Dimerization of Terminal Aziridines to (E)-but-2-ene-1,4-diamines
- •Problem 3: Thiourea-Mediated Conversion of Alcohols to Alkylhalides
- •Problem 8: α-Amination of Amides
- •Problem 9: α-Oxidation of Amides
- •Problem 10: Tsunoda Reagent for Mitsunobu Reaction
- •Problem 11: Preparation of Arylacetonitriles from Arylbromides
- •Problem 12: Transformation of Aromatic Bromides into Aromatic Nitriles
- •Problem 14: Synthesis of Disubstituted Malononitriles
- •Problem 15: Preparation of 2-Arylacetonitriles from Aromatic Ketones
- •4.2 Formation of Hydrazine Derivatives
- •Problem 18: Preparation of Hydrazines from Amines by Using Oxaziridines
- •Problem 19: Preparation of Hydrazines from Alcohols
- •Problem 20: Synthesis of Arylacetohydrazonoyl Cyanide
- •4.3 Formation of Cyclic Alkane and Derivatives
- •4.3.1 Cyclopropane
- •Problem 22: Synthesis of Cyclopropylamines
- •Problem 23: Formation of Cyclopropane by Dialkylation of Active Methylene
- •Problem 24: A Tandem Cyclopropanation Ring-Expansion Reaction
- •4.3.2 Cyclobutane
- •Problem 25: Synthesis of 3-Ethylbicyclo[3.2.0]hept-3-en-6-one
- •4.3.3 Cyclopentane
- •4.3.4 Cycloheptane
- •4.4 Formation of Aromatic Compounds
- •Problem 29: Formation of Hexasubstituted Benzene Ring by Cyclization
- •Problem 31: Synthesis of Tetralone from 1-Naphthol and 1,2-Dichlorobenzene
- •4.5 Formation of Nonaromatic Heterocycles
- •4.5.1 Lactone
- •Problem 32: Preparation of Thiolactone from Lactone
- •Problem 33: Preparation of D-Erythronolactone from Erythorbic Acid
- •Problem 34: Synthesis of L-lyxonolactone-2,3-O-isopropylidene
- •Problem 35: Thermal Rearrangement of Ozonides
- •4.5.2 Hydrofuran
- •4.5.3 Tetrahydropyran
- •Problem 38: Construction of Fosdenopterin Core by Viscontini Reaction
- •4.5.4 Pyrrolidine
- •Problem 40: Synthesis of trans-3-substituted Proline Derivatives
- •Problem 43: Synthesis of Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one
- •4.5.5 Piperidine
- •Problem 45: Preparation of a Spiropiperidine
- •Problem 46: Dealkylation of Tertiary Amine with DEAD
- •Problem 48: Construction of Morphine Core by Acid Promoted Cyclization
- •Problem 49: Preparation of 8a-Phenyloctahydroquinolin-4a(2H)-ol
- •Problem 50: Preparation of an Octahydroquinolizine
- •Problem 51: Preparation of a Chromeno[3,2-i]quinolizine
- •4.5.6 Imidazoline
- •Problem 52: Preparation of Phenytoins from Benzils
- •4.5.7 Oxazolidine
- •4.5.8 Tetrahydropyrimidine
- •Problem 54: Synthesis of Tetrahydropyrimidinol
- •4.5.9 Diazepine
- •Problem 55: Synthesis of 2,3,4,5-Tetrahydro-1H-benzo[e][1,4]diazepine
- •4.5.10 Trioxane
- •Problem 57: Synthesis of 1,2,4-Trioxanes from 4-Alkylphenols and Aldehydes
- •4.6 Formation of Monocyclic Aromatic Heterocycles
- •4.6.1 Oxathiolane
- •Problem 59: Synthesis of Substituted 1,3-Oxathiolane
- •4.6.2 Pyrrole
- •Problem 60: Preparation of Pyrrole-2-Aldehyde from Pyrrole-2-t-butyl ester
- •Problem 61: Synthesis of 2-Formylpyrroles from Pyridinium Iodide Salts
- •Problem 62: Preparation of 2-Aminopyrroles
- •Problem 63: Synthesis of 3-(3,4-Dihydro-2H-pyrrol-5-yl)pyridine (Myosmine)
- •4.6.3 Thiophene
- •Problem 65: Synthesis of Trisubstituted Thiophene
- •4.6.4 Pyrrol-2-one
- •Problem 66: Preparation of Spiro 1H-Pyrrol-2(5H)-ones by One-Pot
- •4.6.5 Pyridine
- •Problem 70: Preparation of Multisubstituted Pyridine
- •Problem 71: Preparation of 4-Perfluoroalkylpyridines
- •Problem 72: C-2 Amination of Pyridine
- •Problem 73: C-2 Amination of Pyridine N-oxide Derivatives
- •Problem 74: Nucleophilic Cyanation of Pyridines
- •Problem 75: Synthesis of 2-Arylpyridines from Acetophenones
- •Problem 76: Preparation of penta-substituted Pyridone
- •4.6.6 Imidazole
- •Problem 77: Formation of 2,4-disubstituted Imidazole
- •Problem 78: Synthesis of Substituted 2-Aryl-N-benzylbenzimidazoles
- •4.6.7 Isoxazole
- •Problem 80: Formation of 5-Chloro-3-phenylbenzo[c]isoxazole
- •Problem 81: Preparation of Isoxazoles from Nitro Compounds and Oxetanes
- •4.6.8 Thiazole
- •Problem 82: Preparation of Thiazole by Thiourea
- •4.6.9 Pyrazole
- •Problem 84: Synthesis of Trifluoromethylpyrazoles
- •Problem 85: Preparation of Pyrazole by Sulfur Extrusion
- •Problem 86: Synthesis of 4-(3-Aminopropyl)-5-amino-1-methylpyrazole
- •The Mechanism
- •4.6.10 Pyrimidine
- •Problem 89: An Industrial Synthesis of Orotic Acid
- •4.6.11 Pyrazine
- •Problem 92: Synthesis of Ethyl 3-(trifluoromethyl)pyrazine-2-carboxylate
- •4.6.12 Triazole
- •Problem 93: Preparation of [1,2,4]Triazolo[1,5-a]pyridin-2-amine
- •4.6.13 Oxadiazole
- •Problem 94: Formation of 1,3,4-Oxadiazole
- •Problem 95: Preparation of 1,2,4-Oxadiazole
- •4.6.14 Thiadiazole
- •Problem 96: Formation of 1,2,4-Thiadiazole
- •4.6.15 Triazine
- •Problem 97: Synthesis of 1,2,3-Triazines
- •4.7.1 Indole
- •Problem 98: Formation of 2,3-Disubstituted Indole
- •4.7.2 Indolizine
- •4.7.3 Quinolone
- •Problem 102: Oxidative Rearrangement of Carboline to Quinolone
- •4.7.4 Indazole
- •Problem 104: Preparation of Indazoles from 2-Methylanilines
- •Problem 106: Synthesis of Indazole by Davis-Beirut Reaction
- •4.7.5 Quinazoline
- •Problem 107: Synthesis of Quinazolines
- •4.7.6 Thienoquinolizine
- •Problem 111: A [3+2] Cycloaddition Followed by Sulfur Extrusion
- •4.7.7 Pyridopyrimidine
- •Problem 112: An Extended Dimroth Rearrangement Catalyzed by MeONa
- •4.7.8 Pyrrolopyrimidine
- •4.7.9 Pyrazolopyrimidine
- •Problem 114: Cyclization of Diazo Compound with Aldehyde
- •4.8 Miscellaneous
- •4.8.1 Steroid
- •4.8.2 Macrolide
- •Problem 117: An Ascomycin Rearrangement
- •4.8.3 Gibberellin
- •Problem 118: An Acyloin Rearrangement in Gibberellin
- •4.8.4 Cannabicitran
- •4.8.5 Serratezomine
- •Problem 120: Transformation of Serratinine into Serratezomine A
- •4.8.6. Vincamine
- •Problem 121: Preparation of Vincamine from Tabersonine
- •References
- •5.1 Formation of Noncyclic Alkane and Derivatives
- •5.1.1 Alcohol
- •Problem 122: An Unexpected Impurity from a Grignard Reaction
- •Problem 124: Formation of an Amidino-Diol Side Product
- •5.1.2 Amine
- •Problem 125: Formation of Ketoamine During Semmler–Wolff Aromatization
- •Problem 126: Formation of an Aniline Impurity by Smiles Rearrangement
- •5.2 Formation of Cyclic Alkane and Derivatives
- •5.2.1 Cyclopropane
- •Problem 127: Formation of a Cyclopropane Impurity
- •5.3 Formation of Aromatic Compounds
- •5.3.1 Benzene
- •Problem 128: Formation of an Undesired Substituted Benzene Side Product
- •5.4 Formation of Nonaromatic Heterocycles
- •5.4.1 Aziridine
- •5.4.2 Pyrrolidine
- •5.4.3 Piperidine
- •Problem 131: An Unusual DAST-Mediated Rearrangement
- •5.4.4 Tetrahydropyrazine
- •Problem 132: Formation of an Unexpected Tetrahydropyrazine Product
- •5.4.5 Tetrahydropyrimidine
- •Problem 133: Formation of Impurities During a CDI-promoted Cyclization
- •5.4.6 Oxazepane
- •Problem 134: An Unusual Stevens Rearrangement Catalyzed by Acid
- •5.4.7 Tetrahydroquinoline
- •5.5 Formation of Monocyclic Aromatic Heterocycles
- •5.5.1 Pyrrole
- •Problem 136: Formation of an Amino Pyrrole Impurity
- •5.5.2 Pyridine
- •Problem 137: Pyridyl Walks to Hydroxyl from Sulfone During an Alkylation
- •5.5.3 Pyrazole
- •5.5.4 Oxazole
- •5.5.5 Triazole
- •5.5.6 Tetrazole
- •Problem 142: Formation of a Tetrazole Impurity Caused by Acetone
- •5.5.7 Diazepine
- •Problem 143: Accidental Discovery of Librium
- •5.6 Formation of Bicyclic Aromatic Heterocycles
- •5.6.1 Benzofuran
- •5.6.2 Benzoxazolinone
- •5.6.3 Quinoline
- •5.6.4 Naphthyridine
- •5.6.5 Pteridine
- •5.7 Miscellaneous
- •5.7.1 Steroid
- •Problem 150: Formation of Impurity F of Clobetasol Propionate
- •Problem 151: Formation of a 24-Methylene Steroidal Impurity
- •5.7.2 Terramycin
- •Problem 152: An Unusual Reaction of Terramycin with Methyl Iodide
- •5.7.3 Cephem
- •Problem 153: Degradation of Cephem Intermediate
- •References
- •Index

Abbreviations xxi
DMF-DMA N,N-dimethylformamide dimethyl acetal
DMMN dimethylmalononitrile
DMPK drug metabolism and pharmacokinetics
DMSO dimethyl sulfoxide
DMTU 1,3-dimethylthiourea
DNA deoxyribonucleic acid
DNBSA 2,4-dinitrobenzenesulfonamide
DOAC direct oral anticoagulant
DOE design of experiment
DPP4 dipeptidyl peptidase-4
DPPA diphenylphosphoryl azide
DQF-COSY double quantum-filtered COSY
ERR1 estrogen-related receptor 1
EUA emergency use authorization
FAK focal adhesion kinase
FCC flush column chromatography
FDA Food and Drug Administration of the United States
GAs gibberellins
GC-MS gas chromatography-mass spectrometry
GK-GKRP glucokinase-glucokinase regulatory protein
GLP Good Laboratory Practices
GMP Good Manufacturing Practices
GPCR G protein-coupled receptor
GPLR G protein-linked receptor
GPR17 G protein-coupled receptor 17
H2L hit to lead
HBTU hexafluorophosphate benzotriazole tetramethyluronium
HCV hepatitis C virus
HFIP hexafluoroisopropanol
HIV human immunodeficiency virus
HMG-CoA 3-hydroxy-3-methylglutaryl (HMG) coenzyme A
HPLC high-performance liquid chromatography
HRMS high-resolution mass spectrometry
HSDD hypoactive sexual desire disorder
HTS high-throughput screening
IND Investigational New Drug Application
IP6K inositol hexakisphosphate kinase
IUPAC International Union of Pure and Applied Chemistry
JAK Janus kinase
LED light emitting diode
LNO 2,6-lutidine N-oxide
LO lead optimization
LSF late stage C─H functionalization
MCL-1 myeloid cell leukemia-1
mCPBA meta-chloroperoxybenzoic acid
MCR multi-component reaction

Abbreviationsxxii
MDM2 mouse double minute 2
MEK mitogen-activated protein kinase
MMA methyl methacrylate
MP melting point
MRSA methicillin-resistant Staphylococcus aureus
MTBE methyl tert-butylether, tert-butylmethyl ether
NBC N-bromocaprolactam
NBS N-bromosuccinimide
NCS N-chlorosuccinimide
NDA new drug application
NMM N-methylmorpholine
NMP N-methyl-2-pyrrolidone
NMPAC National Medical Products Administration of China
NMR nuclear magnetic resonance
NtRTI nucleotide reverse transcriptase inhibitor
OA orotic acid
OECD Organization for Economic Cooperation and Development
OLM olmesartan medoxomil
PARP poly (ADP-ribose) polymerase
PD pharmacodynamics
PDE IV phosphodiesterase-4
PDE-V phosphodiesterase V
PDGFR platelet-derived growth factor receptors
PFA perfluoroalkoxy, Teflon® PFA
PK pharmacokinetics
Plk polo-like kinase
Plk1 polo-like kinase 1
PNP peripheral neuropathic pain
PPAR peroxisome proliferator–activated receptor
PTFE polytetrafluoroethylene
PTLC preparative thin layer chromatography
QSAR quantitative structure-activity relationship
RCM ring-closing metathesis
RNA ribonucleic acid
ROCK1 rho-associated kinase isoform 1
RRT relative retention time
SAR structure–activity relationship
SARS-CoV-2 severe acute respiratory syndrome coronavirus 2
SHP2 Src homology-2 domain-containing protein tyrosine
phosphatase-2
TBAF tetra-n-butylammonium fluoride
TBDPS tert-butyldiphenylsilyl
TBHP tert-butyl hydroperoxide
TBME tert-butylmethyl ether
t-BuONSO N-sulfinyl-O-(tert-butyl)hydroxylamine
TEA triethylamine

Abbreviations xxiii
TFA trifluoroacetic acid
TFAA trifluoroacetic anhydride
THF tetrahydrofuran
TIPS triisopropylsilyl
TLC thin layer chromatography
TMP 2,2,6,6-tetramethylpiperidine
TMSCl trimethylsilyl chloride or chlorotrimethylsilane
TMSOTf trimethylsilyl trifluoromethanesulfonate
TPP tetraphenylporphyrin
TPS tert-butyldiphenylsilyl, TBDPS
TRK tropomyosin receptor kinase
TRPV1 transient receptor potential cation channel subfamily V
member 1
TV target validation
USP upstream processing
UV ultraviolet
VEGFR vascular endothelial growth factor receptor

1.1 Be a “Doctor,” Not Just a “Drug Fetcher”
Even after more than 40 years, I still vividly recall the advice my professor shared
with us during my college organic chemistry experiments. He said, “When con-
ducting a synthetic reaction, it’s essential to grasp the reaction mechanism and the
principles behind each step of the process. It’s similar to how a physician prescribes
medication based on a patient’s condition. If you merely follow the prescription to
prepare the medication, you’ll always remain a ‘drug fetcher,’ never a doctor.” I don’t
intend to diminish the role of a “drug fetcher” in any way. The key issue is that our
aim in training organic chemists is to cultivate “doctors,” not just “drug fetchers.”
Understanding the reaction mechanism allows you to master it, draw connections,
design better experimental procedures, and tackle challenges in your research. For
this reason, comprehending the mechanisms of organic reactions is a fundamental
skill for any synthetic organic chemist.
1.2 Synthetic Organic Chemistry: Still as Much an Art
as a Science
During my tenure as a university professor, one of my responsibilities was over-
seeing students conducting organic chemistry experiments in the laboratory.
I frequently came across an intriguing scenario: despite following the same exper-
imental procedure, students would obtain varying yields and qualities of the prod-
uct. In certain extreme cases, some students failed to produce any of the intended
product, resulting in a failed experiment. This highlighted the challenges of reli-
ability and reproducibility in synthetic chemistry.
When it comes to the reliability and reproducibility of published articles, I con-
sider the annual journal Organic Syntheses to be the top-ranked among organic
chemistry journals. This is primarily because the procedures featured in this journal
are rigorously verified by an independent group of chemists. However, even in such
cases, each synthetic reaction typically yields a range of results or varying yields
across different batches, rather than a fixed value.
1
Opinions and Suggestions

1 Opinions and Suggestions2
The yield of a reaction is influenced by numerous factors, including temper-
ature, concentration, the order and speed of reagent addition, stirring method
and speed, solvent choice, catalyst, the suppliers and purities of starting mate-
rials and reagents, reaction scale, workup procedures, and purification methods.
Even when all these external factors are carefully controlled, different chemists
may still achieve different yields. Furthermore, for a particular chemist, yields
can vary from one batch to another. This indicates that the yield of a synthesis
depends not only on the reaction conditions but also on the individual performing
the experiment—the chemist.
In this sense, while synthetic organic chemistry is undeniably a science, it also
retains a significant degree of artistry. The skill, intuition, and experience of the
chemist play a crucial role in the success of a reaction, making it as much an art as
it is a scientific discipline.
1.3 Synthetic Organic Chemistry Is an Experimental
Science under the Guidance of Theory
Whether an organic reaction is described detail in a textbook, in a reference book, or
in a journal-published article, replicating or referencing these experimental proce-
dures can sometimes lead to issues of varying degrees. Any seemingly insignificant
error could cause a reaction failure or lead to a different result from those reported.
Occasionally, some planned synthetic reactions yield unexpected products or side
products. On the other hand, many groundbreaking organic reactions have been
discovered serendipitously. This unpredictability makes synthetic organic chemistry
both challenging and fascinating. As a result, synthetic organic chemistry remains,
and will continue to be, an experimental science.
Organic chemistry is grounded in a solid theoretical framework, which has
been developed and refined by skilled chemists over centuries. These theories are
built upon the vast body of experimental data accumulated through the collective
efforts of countless chemists over hundreds of years. Understanding and explain-
ing organic reaction mechanisms relies heavily on these established principles. In
the field of medicinal chemistry, particularly in synthetic work, a deep mastery of
organic chemistry theory and a thorough familiarity with various reaction mech-
anisms can significantly enhance the efficiency and productivity of our synthetic
designs and practices. Therefore, organic synthesis is not merely an experimental
science but one that is profoundly guided by theoretical insights.
1.4 Reduce Mistakes in Your Synthetic Work
Given the above considerations, it is imperative that chemists at all levels have oppor-
tunities to enhance their knowledge, experience, and skills throughout their careers.
Many of us spend more than 8 hours a day in the lab, 6 days a week. But does this
alone make us productive chemists? The answer is not necessarily. While dedicating

1.5 Your Knowledge, Experience, and Skills Can Never Be Too Much 3
a certain number of hours to lab work each day is a necessary condition for produc-
tivity, it is not sufficient on its own. The true measure lies in the efficiency of our work.
A common question I receive from graduate students and colleagues I supervise is:
How can we improve the efficiency and quality of our synthetic work? My response
is straightforward: by minimizing or even eliminating mistakes in our work, thereby
increasing the success rate of our synthetic reactions. If every reaction we conducted
were successful, it would undoubtedly be the most efficient way to work. However,
in practice, this is nearly impossible. Therefore, the best approach to enhancing pro-
ductivity is to reduce errors and improve the success rate of our synthetic reactions.
To achieve this, it is crucial to completely understand the mechanism of every
synthetic reaction we perform. We can drastically reduce mistakes by anticipating
potential problems and devising strategies to avoid them. This proactive approach
not only improves the quality of our work but also enhances overall efficiency,
making us more productive chemists in the long run.
1.5 Your Knowledge, Experience, and Skills Can Never
Be Too Much
For any entry-level synthetic chemist fresh out of university—whether you hold a
bachelor’s degree or a Ph.D. with postdoctoral research experience—working as a
medicinal chemist in drug discovery, your knowledge, experience, and skills will
always feel insufficient. Mistakes are inevitable in the early stages of your career.
However, if you are a quick learner, you will rapidly grow by learning from your
own work and the expertise of others. By striving to understand the mechanism
behind every reaction you perform, your problem-solving abilities will improve
significantly. Over time, as you accumulate more knowledge and experience, the
frequency of errors in your synthetic work will steadily decrease.
I’ve heard hiring managers or HR professionals use the term “overqualified”
as a reason to reject certain applicants for a position. However, when it comes to
performing a synthesis, no chemist, regardless of their experience level, can ever be
considered “overqualified.” For even the most experienced chemist, a lack of cau-
tion during a synthetic reaction can result in failure. Experience doesn’t eliminate
the need for careful attention to detail—it reinforces it.
Synthetic organic chemistry is a rapidly evolving field, continuously advancing
with the emergence of new synthetic methods, innovative reagents, and cutting-edge
technologies. These developments are documented in a growing number of articles
published across various organic chemistry journals. The volume of published
research is expanding, and new journals dedicated to organic synthesis are also being
established. Given the finite nature of time and energy, it is challenging to keep up with
every new paper relevant to your work. Nevertheless, it is feasible to efficiently skim
through titles and abstracts to identify key publications. When a paper particularly
captures your interest, you can delve into it in greater detail. While the papers you read
may not always directly contribute to your current projects, maintaining this habit
over the long term can significantly enhance your expertise and benefit your career.

1 Opinions and Suggestions4
1.6 What Is a Mistake?
What is a mistake? From my perspective, it is a relative term or concept. A synthetic
plan or experimental design created by a relatively junior chemist might be consid-
ered reasonable or acceptable. However, the same plan could be seen as an obvious
mistake if it were designed by a more experienced, senior-level chemist. For in-
stance, consider a medicinal chemistry project where the goal is to synthesize a
series of aromatic ethers (1) featuring a difluoro alkyl branch, aiming for final com-
pounds in the range of 5–10 mg. Your proposed synthesis design for compound 1
(R
2
= Me) is shown below.
The target compounds could be synthesized from phenol 2 (suppose 2 have been
prepared or commercially available) and alcohol 3. You find 3 (R
2
= Me) is commer-
cially available, but very expensive (Sigma-Aldrich, US$1746/1 g, US$220/mmol).
So, you decide to prepare 3 (R
2
= Me) from the relatively less expensive diol 4
(AK Scientific, US$162/5 g, US$3.63/mmol) by iteroselective monomethylation. You
also find references (a, US2013/0131050, A1. b, J. Med. Chem., 2021, 64, 14773) sup-
porting your design. The analogs 3b (R
2
= Et) and 3c (R
2
= i − Pr) could be pre-
pared similarly.
If you are a junior-level chemist and have proposed such a design, the two-step
synthesis appears reasonable at first glance, making your design acceptable in prin-
ciple. However, this acceptance does not necessarily mean your design is suitable for
actual synthesis. While the Mitsunobu reaction step is unlikely to pose significant
issues, a more thorough analysis reveals that the first step—preparing ether 3 from
diol 4—could be problematic. If you were to attempt this synthesis in the lab, you
would almost certainly encounter difficulties in isolating product 3 from the reac-
tion mixture.
OH
O
R
1
R
2
F F
O
+
F F
O
HO
1
2
3
Selective
methylation
F F
OH
HO
4
Mitsunobu
reaction
for R
2
=Me
R
1
R
2
R
2
=Me, Et, i-Pr
HO
O
F F
HO
OH
F
F
NaH, THF
MeI, rt
15%
4 (1.121 g)
3 (191 mg)
J. Med. Chem., 2021, 64, 14773
US2013/0131050, A1
O
OH
+
HO
Ph
3
P, DEAD
DCM, 20 °C, 3 h
5
6
O
O
7
CF
3
86%
CF
3

1.6 What Is a Mistake? 5
The patent procedure for this step involves diluting the reaction mixture with
water, extracting with ethyl acetate, evaporating the solvents under reduced
pressure, and further purifying the crude product via silica gel column chromatog-
raphy using an ethyl acetate-hexane eluent, followed by another round of solvent
evaporation. Despite this extensive process, the yield of product 3 was only 15%.
If you were to replicate this procedure, you might initially obtain no product at
all. Detecting compound 3 would also be challenging, as it lacks ultraviolet (UV)
absorption, making it difficult to identify using thin-layer chromatography (TLC) or
high-performance liquid chromatography (HPLC).
Moreover, the situation is further complicated by the likelihood that compound
3 is volatile. Although no boiling point is reported for 3, a structurally similar
compound, 3-methoxy-1-propanol, has a boiling point of approximately 150 °C at
760 mmHg or 45 °C at 10 mmHg. This suggests that during rotary evaporation, the
product could easily be lost—either carried over into the receiving flask with the
solvents or even drawn into the vacuum pump and released into the air. This issue
is particularly pronounced when the reaction is conducted on a small scale (e.g.,
<5 g), which explains the poor yield (15%) reported in the patent.
Another limitation of this design is the lack of divergent synthesis. The iterose-
lective monomethylation of diol 4 in the initial step prevents the synthesis of other
analogs (where R
2
= Et, i − Pr, etc.) from a shared intermediate.
In summary, while your design is conceptually sound, practical challenges in iso-
lating and purifying compound 3 make it less viable for actual laboratory synthesis.
Therefore, if you are a senior-level chemist, creating a design as described above
would be considered an “obvious mistake.”
A more logical and appropriate design is presented below.
The iteroselective mono protection of diol 4 with tert-butyldiphenylsilyl chloride
(TBDPSCl) was reported in many patents and journal articles (e.g., J. Med. Chem.,
2021, 64, 11841).
OH
R
1
O
F F
O
+
F F
OTBDPS
HO
1
2
10
Selective
protection
F F
OH
HO
4
Mitsunobu
reaction
Alkylation
O
F F
OH
8
Deprotection
O
F F
OTBDPS
9
R
1
R
1
R
1
R
2
HO
OTBDPS
F F
HO
OH
F F
NaH, THF
TBDPSCl, rt
72%
4
10
J. Med. Chem., 2021, 64, 11841

1 Opinions and Suggestions6
In the synthesis of the methyl ether product 1, although this design involves
two additional reaction steps compared to the previous approach due to the
introduction of the TBDPS-protecting group, the significantly higher molecular
weight of compound 10 relative to ether 3 ensures that it is less prone to evapora-
tion. This intermediate is also UV-active, as it contains two benzene rings, mak-
ing it detectable by TLC and analytical HPLC. The subsequent steps, including
the Mitsunobu reaction, deprotection, and methylation, are expected to proceed
without issues. Additionally, this design positions alkylation as the final step,
maintaining the flexibility to synthesize other homologues from the common
intermediate 8.
Nevertheless, if the goal is to synthesize hundreds of grams or even kilograms of
compound 3, the first design would be more practical. This is because, on such a
scale, compound 3 could be purified by fractional distillation.
1.7 Beyond Experience: Combining Literature
and Insight for Optimal Synthetic Design
In the field of medicinal chemistry, once the structures of a series of com-
pounds to be synthesized are finalized, the subsequent step involves designing
the synthesis. Even if you are a highly knowledgeable and experienced expert,
it is essential to consult the literature while incorporating your own ideas. This
approach ensures the development of the most rational and feasible synthetic
route. Relying solely on personal experience for synthetic design often does not
yield the best results.
Every stage of the reaction, from the raw materials to the final product, must be
meticulously examined. It is also crucial to prepare contingency plans to address
potential challenges and issues. For multi-step syntheses, the yield of each reac-
tion step, as well as the overall yield, should be estimated. This allows for the
determination of the initial reaction scale based on the required quantity of the
target product.
In multi-step syntheses, it is imperative to avoid using all or most of an intermediate
for the next reaction until a smaller-scale test reaction has been successfully com-
pleted. This precaution holds true even for traditional reactions that appear to be
problem-free, as unexpected complications can arise.
1.8 Improve Your Decision-Making Ability
Modern online search engines like SciFinder and Reaxys are incredibly powerful
tools. When searching for a specific reaction or the synthesis of a particular
compound, these platforms can generate thousands of results in mere seconds.
However, the challenge you face is not a lack of information but an overwhelming
abundance of it. If you find yourself considering 10 out of 100 plausible options
as worth trying, it essentially means you are uncertain. (Having too many

1.9 Know the Mechanism of the Reactions You Perform 7
options can be as paralyzing as having none!) The key is to prioritize these
reaction conditions and select only two or three to test, based on the resources
available in your research facility.
So, how can you enhance your decision-making process? The solution lies
in developing a deep understanding of the reaction mechanism. This includes
a solid understanding of the structural features, as well as the physical and
chemical properties of the starting materials, reagents, catalysts, and products
involved. With this knowledge, you can anticipate potential challenges, such as
reaction selectivity, the need for functional group protection, compatibility bet-
ween functional groups and reaction conditions, side reactions, and the intri-
cacies of workup and purification. By addressing these factors proactively, you
can refine every detail of your synthetic approach. This meticulous preparation
will naturally lead to a higher success rate and improved yields in your synthetic
reactions.
1.9 Know the Mechanism of the Reactions You Perform
At the start of a medicinal chemistry career, particularly for research assistants
or associates, it’s common to follow synthetic designs and references provided
by a supervisor rather than creating your own. In such cases, you may not need
to design the synthesis yourself. However, if you lack an understanding of the
reaction mechanisms involved, mistakes are likely to occur during your work.
While thoroughly reviewing the synthetic design and deciphering the reaction
mechanisms requires extra time and effort, it is a crucial step for professional
growth. Human nature often leans toward taking the path of least resistance—if
one can perform tasks without deep thinking, they may avoid it. But if you are
genuinely committed to enhancing your professional skills and problem-solving
abilities, investing energy in understanding reaction mechanisms will signifi-
cantly improve your work efficiency and accelerate your development.
If you simply follow the synthetic design and references provided by your super-
visor without engaging deeply, you may blame the design or reference method
when a reaction fails, claiming it “doesn’t work.” This passive attitude will not help
you improve your problem-solving skills. Ultimately, you are responsible for your
reactions. Frustration can set in after a week of unsuccessful attempts, making work
feel like a burden and a source of stress.
On the other hand, if you actively engage in the synthetic design and develop
a clear understanding of each reaction’s mechanism, you gain control over
the process. The molecules in your flask will transform into new compounds
as you direct. When your reactions and syntheses proceed smoothly, yielding
the desired products as planned, you’ll experience a profound sense of accom-
plishment and success. This approach not only enhances your skills but also
brings joy and satisfaction to your work, making it a rewarding and fulfilling
experience.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
